Welcome to LookChem.com Sign In|Join Free

CAS

  • or

131206-60-5

Post Buying Request

131206-60-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

131206-60-5 Usage

Description

(+/-)-N N-DIMETHYL-3 4-METHYLENEDIOXYAM&, also known as MDMA or ecstasy, is a psychoactive drug belonging to the amphetamine class. It acts as a serotonin, norepinephrine, and dopamine releasing agent, producing euphoric and empathogenic effects.
Used in Recreational Industry:
(+/-)-N N-DIMETHYL-3 4-METHYLENEDIOXYAM& is used as a recreational drug for its euphoric and empathogenic effects, allowing users to experience heightened sensations and emotional closeness.
Used in Therapeutic Applications:
(+/-)-N N-DIMETHYL-3 4-METHYLENEDIOXYAM& is used as a potential treatment for post-traumatic stress disorder (PTSD) and other psychiatric conditions, due to its ability to facilitate emotional processing and communication.
Note: The use of (+/-)-N N-DIMETHYL-3 4-METHYLENEDIOXYAM& for recreational purposes is illegal in many countries due to its potential for abuse and harm. Additionally, it can have serious adverse effects, including anxiety, agitation, insomnia, and neurotoxicity, especially with long-term or high-dose use.

Check Digit Verification of cas no

The CAS Registry Mumber 131206-60-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,1,2,0 and 6 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 131206-60:
(8*1)+(7*3)+(6*1)+(5*2)+(4*0)+(3*6)+(2*6)+(1*0)=75
75 % 10 = 5
So 131206-60-5 is a valid CAS Registry Number.

131206-60-5Downstream Products

131206-60-5Relevant articles and documents

Binding mode selection determines the action of ecstasy homologs at monoamine transporters

Sandtner, Walter,Stockner, Thomas,Hasenhuetl, Peter S.,Partilla, John S.,Seddik, Amir,Zhang, Yuan-Wei,Cao, Jianjing,Holy, Marion,Steinkellner, Thomas,Rudnick, Gary,Baumann, Michael H.,Ecker, Gerhard F.,Newman, Amy Hauck,Sitte, Harald H.

, p. 165 - 175 (2016)

Determining the structural elements that define substrates and inhibitors at the monoamine transporters is critical to elucidating the mechanisms underlying these disparate functions. In this study, we addressed this question directly by generating a series of N-substituted 3,4-methylenedioxyamphetamine analogs that differ only in the number of methyl substituents on the terminal amine group. Starting with 3,4-methylenedioxy-N-methylamphetamine, 3,4-methylenedioxy-N,N-dimethylamphetamine (MDDMA) and 3,4-methylenedioxy-N,N,N-Trimethylamphetamine (MDTMA) were prepared. We evaluated the functional activities of the compounds at all three monoamine transporters in native brain tissue and cells expressing the transporters. In addition, we used ligand docking to generate models of the respective proteinligand complexes, which allowed us to relate the experimental findings to available structural information. Our results suggest that the 3,4-methylenedioxyamphetamine analogs bind at the monoamine transporter orthosteric binding site by adopting one of two mutually exclusive binding modes. 3,4-methylenedioxyamphetamine and 3,4-methylenedioxy-N-methylamphetamine adopt a high-Affinity binding mode consistent with a transportable substrate, whereas MDDMA and MDTMA adopt a lowaffinity binding mode consistent with an inhibitor, in which the ligand orientation is inverted. Importantly, MDDMA can alternate between both binding modes, whereas MDTMA exclusively binds to the low-Affinity mode. Our experimental results are consistent with the idea that the initial orientation of bound ligands is critical for subsequent interactions that lead to transporter conformational changes and substrate translocation.

Research on the central activity and analgesia of N-substituted analogs of the amphetamine derivative 3,4-methylenedioxyphenylisopropylamine

Braun,Shulgin,Braun

, p. 825 - 830 (2007/10/02)

N-substituted analogs of 3,4-methylenedioxyphenylisopropylamine (MDA) were tested ror analgesic potency and influence on motor activity in mice following potency and influence on motor activity in mice following oral administration. These compounds also were tested for thei psychotomimetic potency in man. Unsubstituted MDA and its monoalkyl-homologs with a low number of C-atoms (N-methyl-, N-methyl-, N-ethyl-MDA) showed both enhancement of motor-activity in mice and psychotomimetic effects in man. MDA and N-methyl-MDA also showed an analgesic effec wthich was enhanced by the inclusion of a weakly labis group (N-mallyl, N-hydroxyethyl). These latter two compounds, however, did not influence motor-activity, which makes them more recommendable as possible analgesic compounds. Structural parallels between these compounds, morphine, endorphins and enkephalins, may explain their similar spectrum of pharmacological effects.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 131206-60-5